Karen Aldred

Prevention of conversion to abnormal transcranial <scp>D</scp>oppler with hydroxyurea in sickle cell anemia: A <scp>P</scp>hase III international randomized clinical trial

Jane S. Hankins, Angela Rankine‐Mullings, Marvin Reid et al. · American Journal of Hematology · 2015 · 77 citations · Full text

Medicine, Hematology, Pediatrics +16

Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial

Angela Rankine‐Mullings, Marvin Reid, Deanne Soares et al. · British Journal of Haematology · 2021 · 27 citations · Full text

Medicine, Hematology, Pharmacology +16

Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition

Angela Rankine‐Mullings, Nadine Morrison‐Levy, Deanne Soares et al. · British Journal of Haematology · 2018 · 23 citations · Full text

Medicine, Hematology, Pediatrics +17

EXpanding Treatment for Existing Neurological Disease (EXTEND): An Open-Label Phase II Clinical Trial of Hydroxyurea Treatment in Sickle Cell Anemia

Angela Rankine‐Mullings, Courtney R Little, Marvin Reid et al. · JMIR Research Protocols · 2016 · 11 citations · Full text

Medicine, Hematology, Neurology +16